BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32741228)

  • 21. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.
    Schwarzwaelder K; Howe SJ; Schmidt M; Brugman MH; Deichmann A; Glimm H; Schmidt S; Prinz C; Wissler M; King DJ; Zhang F; Parsley KL; Gilmour KC; Sinclair J; Bayford J; Peraj R; Pike-Overzet K; Staal FJ; de Ridder D; Kinnon C; Abel U; Wagemaker G; Gaspar HB; Thrasher AJ; von Kalle C
    J Clin Invest; 2007 Aug; 117(8):2241-9. PubMed ID: 17671654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
    Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
    Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.
    Zhang F; Thornhill SI; Howe SJ; Ulaganathan M; Schambach A; Sinclair J; Kinnon C; Gaspar HB; Antoniou M; Thrasher AJ
    Blood; 2007 Sep; 110(5):1448-57. PubMed ID: 17456723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia.
    Ginn SL; Curtin JA; Kramer B; Smyth CM; Wong M; Kakakios A; McCowage GB; Watson D; Alexander SI; Latham M; Cunningham SC; Zheng M; Hobson L; Rowe PB; Fischer A; Cavazzana-Calvo M; Hacein-Bey-Abina S; Alexander IE
    Med J Aust; 2005 May; 182(9):458-63. PubMed ID: 15865589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1.
    Touzot F; Moshous D; Creidy R; Neven B; Frange P; Cros G; Caccavelli L; Blondeau J; Magnani A; Luby JM; Ternaux B; Picard C; Blanche S; Fischer A; Hacein-Bey-Abina S; Cavazzana M
    Blood; 2015 Jun; 125(23):3563-9. PubMed ID: 25869287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.
    Wang GP; Berry CC; Malani N; Leboulch P; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Bushman FD
    Blood; 2010 Jun; 115(22):4356-66. PubMed ID: 20228274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.
    Gaspar HB; Cooray S; Gilmour KC; Parsley KL; Adams S; Howe SJ; Al Ghonaium A; Bayford J; Brown L; Davies EG; Kinnon C; Thrasher AJ
    Sci Transl Med; 2011 Aug; 3(97):97ra79. PubMed ID: 21865537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene correction for SCID-X1 in long-term hematopoietic stem cells.
    Pavel-Dinu M; Wiebking V; Dejene BT; Srifa W; Mantri S; Nicolas CE; Lee C; Bao G; Kildebeck EJ; Punjya N; Sindhu C; Inlay MA; Saxena N; DeRavin SS; Malech H; Roncarolo MG; Weinberg KI; Porteus MH
    Nat Commun; 2019 Apr; 10(1):1634. PubMed ID: 30967552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs.
    Girard-Gagnepain A; Amirache F; Costa C; Lévy C; Frecha C; Fusil F; Nègre D; Lavillette D; Cosset FL; Verhoeyen E
    Blood; 2014 Aug; 124(8):1221-31. PubMed ID: 24951430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency.
    Bernadin O; Amirache F; Girard-Gagnepain A; Moirangthem RD; Lévy C; Ma K; Costa C; Nègre D; Reimann C; Fenard D; Cieslak A; Asnafi V; Sadek H; Mhaidly R; Cavazzana M; Lagresle-Peyrou C; Cosset FL; André I; Verhoeyen E
    Blood Adv; 2019 Feb; 3(3):461-475. PubMed ID: 30755435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
    Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
    Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys.
    Carbonaro Sarracino D; Tarantal AF; Lee CC; Martinez M; Jin X; Wang X; Hardee CL; Geiger S; Kahl CA; Kohn DB
    Mol Ther; 2014 Oct; 22(10):1803-16. PubMed ID: 24925206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.
    van der Loo JC; Swaney WP; Grassman E; Terwilliger A; Higashimoto T; Schambach A; Hacein-Bey-Abina S; Nordling DL; Cavazzana-Calvo M; Thrasher AJ; Williams DA; Reeves L; Malik P
    Gene Ther; 2012 Aug; 19(8):872-6. PubMed ID: 22551777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrome signatures of lentiviral gene therapy for SCID-X1 patients.
    Yan KK; Condori J; Ma Z; Metais JY; Ju B; Ding L; Dhungana Y; Palmer LE; Langfitt DM; Ferrara F; Throm R; Shi H; Risch I; Bhatara S; Shaner B; Lockey TD; Talleur AC; Easton J; Meagher MM; Puck JM; Cowan MJ; Zhou S; Mamcarz E; Gottschalk S; Yu J
    Sci Adv; 2023 Oct; 9(40):eadg9959. PubMed ID: 37801507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Conditioning and Lentiviral Vector Pseudotype on Short- and Long-Term Airway Reporter Gene Expression in Mice.
    Carpentieri C; Farrow N; Cmielewski P; Rout-Pitt N; McCarron A; Knight E; Parsons D; Donnelley M
    Hum Gene Ther; 2021 Aug; 32(15-16):817-827. PubMed ID: 33947249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction.
    Xu F; Liu X; Zhang D; Zhao F; Fan Z; Hu S; Mei S; Huang Y; Sun H; Wei L; Guo L; Wang J; Cen S; Liang C; Guo F
    Hum Gene Ther; 2021 Sep; 32(17-18):936-948. PubMed ID: 33678011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.
    Blanco E; Izotova N; Booth C; Thrasher AJ
    Front Immunol; 2020; 11():608653. PubMed ID: 33329605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells.
    Davis BM; Humeau L; Slepushkin V; Binder G; Korshalla L; Ni Y; Ogunjimi EO; Chang LF; Lu X; Dropulic B
    Blood; 2004 Jul; 104(2):364-73. PubMed ID: 15059841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.
    Kim YS; Wielgosz MM; Hargrove P; Kepes S; Gray J; Persons DA; Nienhuis AW
    Mol Ther; 2010 Jul; 18(7):1310-7. PubMed ID: 20372106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant
    Petrillo C; Calabria A; Piras F; Capotondo A; Spinozzi G; Cuccovillo I; Benedicenti F; Naldini L; Montini E; Biffi A; Gentner B; Kajaste-Rudnitski A
    Hum Gene Ther; 2019 Sep; 30(9):1133-1146. PubMed ID: 31037976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.